Baiteng Zhao
CIK: 0002049287
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Whitehawk Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 12, 2026WHWK
Whitehawk Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
38K shares- - Jun 17, 2025WHWK
Whitehawk Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
40K shares- - Mar 4, 2025AADI
Aadi Bioscience, Inc.
Award(A)Indirect1.3M shares at avg. $2.40$3.0M - Dec 19, 2024AADI
Aadi Bioscience, Inc.
Award(A)DirectStock Option (right to buy)
61.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 12, 2026 | WHWK Whitehawk Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 38,040 | - | - | Direct |
| Jun 17, 2025 | WHWK Whitehawk Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 40,006 | - | - | Direct |
| Mar 4, 2025 |  AADI Aadi Bioscience, Inc. | Award(A) | 1,250,000 | $2.40 | $3,000,000 | Indirect |
| Dec 19, 2024 | AADI Aadi Bioscience, Inc. | Award(A) Stock Option (right to buy) | 61,192 | - | - | Direct |
1-4 of 4 transactions
About Zhao Baiteng
Zhao Baiteng (SEC CIK 0002049287) files insider reports with the SEC as Director of Whitehawk Therapeutics, Inc. (WHWK).
Signal8 holds 5 ownership filings by Zhao Baiteng (1 Form 3, 4 Form 4), filed between Dec 23, 2024 and Jun 15, 2026. Those filings report 4 transactions, from Dec 19, 2024 to Jun 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Zhao Baiteng's filings is in MORRISTOWN, NJ.
Recent filings by Zhao Baiteng
Other insiders filing for Whitehawk Therapeutics, Inc. (WHWK)
- Giacobello Scott M., CHIEF FINANCIAL OFFICER
- BALL BRYAN
- Dornan David, Chief Scientific Officer
- Lennon David James, CHIEF EXECUTIVE OFFICER
- Dugan Margaret, Chief Medical Officer
- Iyengar Vijay K, Director